United States
Germany
Japan
United Kingdom
China
KRAS (Myc-DDK-tagged)-Human v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog (KRAS), transcript variant b
| Type | Human Tagged ORF Clone |
| Tag | Myc-DDK |
| Vector | pCMV6-Entry |
Products
KRAS mutant (G12D), Myc-DDK-tagged ORF clone of Homo sapiens v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog (KRAS), transcript variant b as transfection-ready DNA
| Mutation | G12D |
| Tag | Myc-DDK |
| Vector | pCMV6-Entry |
- TrueORF®
Recombinant protein of human v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog (KRAS), transcript variant b, 20 µg
| Tag | C-Myc/DDK |
| Expression Host | HEK293T |
KRAS mutant (G12D) Myc-DDK-tagged human recombinant protein of Homo sapiens v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog (KRAS), transcript variant b
| Tag | C-Myc/DDK |
KRAS mutant (G12V), Myc-DDK-tagged ORF clone of Homo sapiens v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog (KRAS), transcript variant b as transfection-ready DNA
| Mutation | G12V |
| Tag | Myc-DDK |
| Vector | pCMV6-Entry |
- TrueORF®
KRAS (Myc-DDK-tagged)-Human v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog (KRAS), transcript variant a
| Type | Human Tagged ORF Clone |
| Tag | Myc-DDK |
| Vector | pCMV6-Entry |
KRAS mutant (G12C), Myc-DDK-tagged ORF clone of Homo sapiens v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog (KRAS), transcript variant b as transfection-ready DNA
| Mutation | G12C |
| Tag | Myc-DDK |
| Vector | pCMV6-Entry |
- TrueORF®
KRAS mutant (G13D), Myc-DDK-tagged ORF clone of Homo sapiens v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog (KRAS), transcript variant b as transfection-ready DNA
| Mutation | G13D |
| Tag | Myc-DDK |
| Vector | pCMV6-Entry |
- TrueORF®
KRAS (tGFP-tagged) - Human v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog (KRAS), transcript variant b
| Type | Human Tagged ORF Clone |
| Tag | TurboGFP |
| Vector | pCMV6-AC-GFP |
- TrueORF®
Recombinant protein of human v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog (KRAS), transcript variant a, 20 µg
| Tag | C-Myc/DDK |
| Expression Host | HEK293T |
KRAS mutant (G12R), Myc-DDK-tagged ORF clone of Homo sapiens v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog (KRAS), transcript variant b as transfection-ready DNA
| Mutation | G12R |
| Tag | Myc-DDK |
| Vector | pCMV6-Entry |
- TrueORF®
KRAS (Human) - 3 unique 27mer siRNA duplexes - 2 nmol each
| Purity | HPLC purified |
| Number of Transfections | Approximately 330 transfections/2nmol in 24-well plate under optimized conditions (final conc. 10 nM). |
SR320806 is the updated version of SR302601.
KRAS (tGFP-tagged) - Human v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog (KRAS), transcript variant a
| Type | Human Tagged ORF Clone |
| Tag | TurboGFP |
| Vector | pCMV6-AC-GFP |
- TrueORF®
KRAS mutant (G12S), Myc-DDK-tagged ORF clone of Homo sapiens v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog (KRAS), transcript variant b as transfection-ready DNA
| Mutation | G12S |
| Tag | Myc-DDK |
| Vector | pCMV6-Entry |
- TrueORF®
KRAS (untagged)-Human v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog (KRAS), transcript variant b
| Type | Human Untagged Clone |
| Tag | Tag Free |
| Vector | pCMV6-XL6 |
活动过滤器
优化搜索结果
Expression Hosts
Lentivirus
Vectors
Reporters
QC Levels
Families
Pathways
- Acute myeloid leukemia (51)
- Axon guidance (51)
- B cell receptor signaling pathway (51)
- Bladder cancer (51)
- Chemokine signaling pathway (51)
- Chronic myeloid leukemia (51)
- Colorectal cancer (51)
- Dorso-ventral axis formation (51)
- Endometrial cancer (51)
- ErbB signaling pathway (51)
- Fc epsilon RI signaling pathway (51)
- Gap junction (51)
- Glioma (51)
- GnRH signaling pathway (51)
- Insulin signaling pathway (51)
- Long-term depression (51)
- Long-term potentiation (51)
- MAPK signaling pathway (51)
- Melanogenesis (51)
- Melanoma (51)
- Natural killer cell mediated cytotoxicity (51)
- Neurotrophin signaling pathway (51)
- Non-small cell lung cancer (51)
- Pancreatic cancer (51)
- Pathways in cancer (51)
- Progesterone-mediated oocyte maturation (51)
- Prostate cancer (51)
- Regulation of actin cytoskeleton (51)
- Renal cell carcinoma (51)
- T cell receptor signaling pathway (51)
- Thyroid cancer (51)
- Tight junction (51)
- VEGF signaling pathway (51)
